Detalhe da pesquisa
1.
DNA Methylation in the Anti-Mullerian Hormone Gene and the Risk of Disease Activity in Multiple Sclerosis.
Ann Neurol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38747444
2.
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis.
Mult Scler
; 27(9): 1374-1383, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32975468
3.
Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patients.
Eur J Neurol
; 28(8): 2513-2522, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864731
4.
A pharmacogenetic study implicates NINJ2 in the response to Interferon-ß in multiple sclerosis.
Mult Scler
; 26(9): 1074-1082, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221001
5.
Laser capture microdissection for transcriptomic profiles in human skin biopsies.
BMC Mol Biol
; 19(1): 7, 2018 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29921228
6.
NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.
Mult Scler
; 24(11): 1507-1510, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29117789
7.
Inverse correlation of genetic risk score with age at onset in bout-onset and progressive-onset multiple sclerosis.
Mult Scler
; 21(11): 1463-7, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25533292
8.
The burden of multiple sclerosis variants in continental Italians and Sardinians.
Mult Scler
; 21(11): 1385-95, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26438306
9.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Mult Scler
; 20(7): 802-11, 2014 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24277324
10.
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(3)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792371
11.
Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach.
J Pers Med
; 13(1)2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675783
12.
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients.
Genes (Basel)
; 13(11)2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36421810
13.
Transcriptional effects of fingolimod treatment on peripheral T cells in relapsing remitting multiple sclerosis patients.
Pharmacogenomics
; 23(3): 161-171, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35068175
14.
BDNF Val66Met Polymorphism Is Associated With Motor Recovery After Rehabilitation in Progressive Multiple Sclerosis Patients.
Front Neurol
; 13: 790360, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35265024
15.
Early use of fingolimod is associated with better clinical outcomes in relapsing-remitting multiple sclerosis patients.
J Neurol
; 269(10): 5596-5605, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759013
16.
Involvement of NINJ2 Protein in Inflammation and Blood-Brain Barrier Transmigration of Monocytes in Multiple Sclerosis.
Genes (Basel)
; 13(11)2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36360183
17.
Clinical and pathological findings in neurolymphomatosis: Preliminary association with gene expression profiles in sural nerves.
Front Oncol
; 12: 974751, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226068
18.
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility.
Genes (Basel)
; 13(12)2022 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36553660
19.
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility.
J Neurol
; 269(8): 4510-4522, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545683
20.
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population.
Front Genet
; 12: 800262, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35047017